What the %*@& Is Going On at the FDA?

Experts want to know why the agency approved a questionable Alzheimer’s drug but has withheld full approval from Covid vaccines.

ACT UP began advocating for HIV/AIDS drugs by protesting outside the FDA. But the activists soon switched to asking NIH for more research on potential medications. Photo: NIH History Office

Six months into Biden’s presidency, the FDA is in turmoil; the administration still hasn’t even named a commissioner to lead the agency. The hasty Aduhelm approval shocked observers, in part because the agency has yet to offer full approval to Covid-19 vaccines despite millions of successful and safe vaccinations. With Pfizer expected to file within weeks for another emergency use authorization for a third Covid booster shot, and the highly contagious delta variant spreading, fully approving the Covid vaccines could offer the country a much-needed vaccination boost. “The FDA is close to hitting rock bottom,” Dr. Gregg Gonsalves, a professor at Yale’s School of Public Health, said. Read more at The New Republic.

Categories: Freelance Articles

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 207 other followers

NBCC Member

%d bloggers like this: